NTB-001

N/A

Report date: 2025/10/15 17:33:48

Base Information

Drug NameNTB-001

Drug Alias NameNTB-001

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAnti-Factor IXaAnti-Factor X

TargetsCoagulation factor XCoagulation factor IX

Therapy Area/IndicationsHemophilia A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesNanjing Zhengda Tianqing Pharmaceutical Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesNanjing Zhengda Tianqing Pharmaceutical Co Ltd

Inactive CompaniesN/A

Active IndicationsHemophilia A

Inactive IndicationsN/A

Other Information

ATC CodeN/A